Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance

Micol Eleonora Fiori, Simone Di Franco, Lidia Villanova, Paola Bianca, Giorgio Stassi, Ruggero De Maria Marchiano*

*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivistaArticolo in rivista

114 Citazioni (Scopus)


In the last decades, the role of the microenvironment in tumor progression and therapeutic outcome has gained increasing attention. Cancer-associated fibroblasts (CAFs) have emerged as key players among stromal cells, owing to their abundance in most solid tumors and their diverse tumor-restraining/promoting roles. The interplay between tumor cells and neighboring CAFs takes place by both paracrine signals (cytokines, exosomes and metabolites) or by the multifaceted functions of the surrounding extracellular matrix. Here, we dissect the most recent identified mechanisms underlying CAF-mediated control of tumor progression and therapy resistance, which include induction of the epithelial-to-mesenchymal transition (EMT), activation of survival pathways or stemness-related programs and metabolic reprogramming in tumor cells. Importantly, the recently unveiled heterogeneity in CAFs claims tailored therapeutic efforts aimed at eradicating the specific subset facilitating tumor progression, therapy resistance and relapse. However, despite the large amount of pre-clinical data, much effort is still needed to translate CAF-directed anti-cancer strategies from the bench to the clinic.
Lingua originaleEnglish
pagine (da-a)70-N/A
RivistaMolecular Cancer
Stato di pubblicazionePubblicato - 2019


  • Cancer-associated fibroblasts


Entra nei temi di ricerca di 'Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance'. Insieme formano una fingerprint unica.

Cita questo